Airflow obstruction and exercise

Respiratory Medicine

Volumn 103, Issue 3, 2009, Pages 325-334

  Cooper, Christopher B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anabolic agents; Bronchodilator agents; Chronic obstructive; Forced expiratory volume; Hyperinflation; Pulmonary disease

Indexed keywords

BRONCHODILATING AGENT; IPATROPIUM; PLACEBO; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE COURSE; DRUG DEPENDENCE; DRUG EFFICACY; DYSPNEA; EXERCISE; HUMAN; HYPERINFLATION; KINESIOTHERAPY; LUNG MECHANICS; LUNG TRANSPLANTATION; LUNG VOLUME; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VACCINATION;

DISEASE PROGRESSION; EXERCISE THERAPY; EXERCISE TOLERANCE; HUMANS; LUNG; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESISTANCE TRAINING; RESPIRATORY MECHANICS;

EID: 59349101543     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.026     Document Type: Review

References (52)

1. Anto J.M., Vermeire P., Vestbo J., and Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 17 5 (2001) 982-994
2. Mannino D., Homa D., Akinbami L., Ford E., and Redd S. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Morb Mortal Wkly Rep 51 SS06 (2002) 1-16
3. Chapman K.R., Tashkin D.P., and Pye D.J. Gender bias in the diagnosis of COPD. Chest 119 6 (2001) 1691-1695
4. Halpin D.M., and Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc 3 7 (2006) 619-623
5. Prescott E. Tobacco-related diseases: the role of gender. An epidemiologic study based on data from the Copenhagen Centre for Prospective Population Studies. Dan Med Bull 47 2 (2000) 115-131
6. Jounieaux V., and Mayeux I. Oxygen cost of breathing in patients with emphysema or chronic bronchitis in acute respiratory failure. Am J Respir Crit Care Med 152 6 Pt 1 (1995) 2181-2184
7. Babb T.G., Viggiano R., Hurley B., Staats B., and Rodarte J.R. Effect of mild-to-moderate airflow limitation on exercise capacity. J Appl Physiol 70 1 (1991) 223-230
8. Cooper C.B. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 119 10 Suppl. 1 (2006) 21-31
9. Pitta F., Troosters T., Spruit M.A., Probst V.S., Decramer M., and Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 9 (2005) 972-977
10. Oga T., Nishimura K., Tsukino M., Sato S., and Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 167 4 (2003) 544-549
11. Myers J., Prakash M., Froelicher V., Do D., Partington S., and Atwood J.E. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346 11 (2002) 793-801
12. Celli B.R., MacNee W., Agusti A., Anzueto A., Berg B., Buist A.S., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 6 (2004) 932-946
13. National Institute for Clinical Excellence (NICE). Chronic obstractive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59 Suppl. 1 (2004)
14. O'Donnell D., Aaron S., Bourbeau J., Hernandez P., Marciniuk D., Balter M., et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2007 update. Can Respir J 14 Suppl. B (2007) 5B-32B
15. Fletcher C., and Peto R. The natural history of chronic airflow obstruction. Br Med J 1 6077 (1977) 1645-1648
16. Foglio K., Carone M., Pagani M., Bianchi L., Jones P.W., and Ambrosino N. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. Respir Med 94 3 (2000) 256-263
17. Kaplan R.M., Ries A.L., Reilly J., and Mohsenifar Z. Measurement of health-related quality of life in the national emphysema treatment trial. Chest 126 3 (2004) 781-789
18. Brown C.D., Benditt J.O., Sciurba F.C., Lee S.M., Criner G.J., Mosenifar Z., et al. Exercise testing in severe emphysema: association with quality of life and lung function. COPD 5 2 (2008) 117-124
19. O'Donnell D.E. Ventilatory limitations in chronic obstructive pulmonary disease. Med Sci Sports Exerc 33 7 Suppl. (2001) S647-S655
20. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2006 executive summary. Available from: .
21. O'Donnell D.E., Lam M., and Webb K.A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 2 (1999) 542-549
22. O'Donnell D.E., Bertley J.C., Chau L.K., and Webb K.A. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 155 1 (1997) 109-115
23. Fromer L., and Cooper C.B. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD. Int J Clin Pract 62 8 (2008) 1219-1236
24. Porszasz J., Emtner M., Goto S., Somfay A., Whipp B.J., and Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 128 4 (2005) 2025-2034
25. Palange P., Valli G., Onorati P., Antonucci R., Paoletti P., Rosato A., et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 97 5 (2004) 1637-1642
26. Pecchiari M., Pelucchi A., D'Angelo E., Foresi A., Milic-Emili J., and D'Angelo E. Effect of heliox breathing on dynamic hyperinflation in COPD patients. Chest 125 6 (2004) 2075-2082
27. Fishman A., Martinez F., Naunheim K., Piantadosi S., Wise R., Ries A., et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348 21 (2003) 2059-2073
28. Appleton S., Adams R., Porter S., Peacock M., and Ruffin R. Sustained improvements in dyspnea and pulmonary function 3 to 5 years after lung volume reduction surgery. Chest 123 6 (2003) 1838-1846
29. Miller J.D., Berger R.L., Malthaner R.A., Celli B.R., Goldsmith C.H., Ingenito E.P., et al. Lung volume reduction surgery vs medical treatment: for patients with advanced emphysema. Chest 127 4 (2005) 1166-1177
30. Hopkinson N.S., Toma T.P., Hansell D.M., Goldstraw P., Moxham J., Geddes D.M., et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 171 5 (2005) 453-460
31. Casaburi R., Porszasz J., Burns M.R., Carithers E.R., Chang R.S., and Cooper C.B. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 155 5 (1997) 1541-1551
32. O'Donnell D.E., Fluge T., Gerken F., Hamilton A., Webb K., Aguilaniu B., et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23 6 (2004) 832-840
33. O'Donnell D., Maltais F., Frith P., Southcott A., Kesten S., and Hamilton A. Perceived locus of symptom limitation during constant work rate cycle ergometry in COPD patients treated with tiotropium. Chest 126 (2004) 838S
34. Maltais F., Hamilton A., Marciniuk D., Hernandez P., Sciurba F.C., Richter K., et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 128 3 (2005) 1168-1178
35. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 6 (2004) 932-946
36. Cooper C.B. Exercise in chronic pulmonary disease: limitations and rehabilitation. Med Sci Sports Exerc 33 7 Suppl. (2001) S643-S646
37. Griffiths T.L., Burr M.L., Campbell I.A., Lewis-Jenkins V., Mullins J., Shiels K., et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 355 9201 (2000) 362-368
38. Casaburi R., Kukafka D., Cooper C.B., Witek Jr. T.J., and Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127 3 (2005) 809-817
39. Bernard S., LeBlanc P., Whittom F., Carrier G., Jobin J., Belleau R., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 2 (1998) 629-634
40. Ries A.L. ACCP/AACVPR evidence-based guidelines for pulmonary rehabilitation. Round 3: another step forward. J Cardiopulm Rehabil Prev 27 4 (2007) 233-236
41. Storer T.W. Exercise in chronic pulmonary disease: resistance exercise prescription. Med Sci Sports Exerc 33 7 Suppl. (2001) S680-S692
42. Revill S.M., Singh S.J., and Morgan M.D. Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. Respir Med 94 8 (2000) 778-783
43. Lacasse Y., Lecours R., Pelletier C., Begin R., and Maltais F. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J 25 6 (2005) 1032-1038
44. van 't Hul A., Gosselink R., Hollander P., Postmus P., and Kwakkel G. Training with inspiratory pressure support in patients with severe COPD. Eur Respir J 27 1 (2006) 65-72
45. Lorenzi C.M., Cilione C., Rizzardi R., Furino V., Bellantone T., Lugli D., et al. Occupational therapy and pulmonary rehabilitation of disabled COPD patients. Respiration 71 3 (2004) 246-251
46. Somfay A., Porszasz J., Lee S.M., and Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur Respir J 18 1 (2001) 77-84
47. Chrystyn H., Mulley B.A., and Peake M.D. Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ 297 6662 (1988) 1506-1510
48. Newton M.F., O'Donnell D.E., and Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 121 4 (2002) 1042-1050
49. O'Donnell D.E., Voduc N., Fitzpatrick M., and Webb K.A. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 24 1 (2004) 86-94
50. O'Donnell D.E., Lam M., and Webb K.A. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 5 Pt 1 (1998) 1557-1565
51. Celli B., ZuWallack R., Wang S., and Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 124 5 (2003) 1743-1748
52. Belman M.J., Botnick W.C., and Shin J.W. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153 3 (1996) 967-975